Coronary Artery Disease
Stent apposition in late and very late stent thrombosis
The apposing views
Matthew I. Tomey MD,
Matthew I. Tomey MD
The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York
Search for more papers by this author Roxana Mehran MD,
Corresponding Author
Roxana Mehran MD
The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York
Correspondence to: Roxana Mehran; The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1030, New York, NY 10029. E-mail:
[email protected]Search for more papers by this author
Matthew I. Tomey MD,
Matthew I. Tomey MD
The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York
Search for more papers by this author Roxana Mehran MD,
Corresponding Author
Roxana Mehran MD
The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York
Correspondence to: Roxana Mehran; The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1030, New York, NY 10029. E-mail:
[email protected]Search for more papers by this author
First published: 20 November 2013
No abstract is available for this article.
REFERENCES
- 1
Pfisterer M,
Brunner-La Rocca HP,
Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584–2591.
- 2
Joner M,
Finn AV,
Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193–202.
- 3
Grines CL,
Bonow RO,
Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Catheter Cardiovasc Interv 2007; 69: 334–340.
- 4
Mehran R,
Baber U,
Steg PG, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet, 2013 Aug 30; [Epub ahead of print]. doi: 10.1016/S0140-6736(13)61720-1.
- 5
Steinberg DH,
Mintz GS,
Mandinov L, et al. Long-term impact of routinely detected early and late incomplete stent apposition: An integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv 2010; 3: 486–494.
